Publications by authors named "Jason R Slizgi"

Claim this Profile
C
Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases.
Andreas Muehler, Jason R Slizgi, Hella Kohlhof, Manfred Groeppel, Evelyn Peelen

World J Gastrointest Pathophysiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease.
William J Brock, James J Beaudoin, Jason R Slizgi, Mingming Su, Wei Jia

Int J Toxicol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transporter-Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate.
Izna Ali, Jason R Slizgi, Josh D Kaullen, Marija Ivanovic, Mikko Niemi

Clin Pharmacol Ther· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Liver Disease on Hepatic Transporter Expression and Function.
Nilay Thakkar, Jason R Slizgi, Kim L R Brouwer

J Pharm Sci· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular Disposition and Transporter Interactions with Tolvaptan and Metabolites in Sandwich-Cultured Human Hepatocytes.
Yang Lu, Jason R Slizgi, Kenneth R Brouwer, Robert L St Claire, Kimberly M Freeman

Drug Metab Dispos· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Human Hepatic Bile Acid Transporters by Tolvaptan and Metabolites: Contributing Factors to Drug-Induced Liver Injury?
Jason R Slizgi, Yang Lu, Kenneth R Brouwer, Robert L St Claire, Kimberly M Freeman

Toxicol Sci· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis